Obesity

Novel epigenetic marks of insulin resistance trajectories in a longitudinal study of childhood obesity

Cardiovasc DiabetolPublished Longitudinal epigenome-wide association study

Authors' conclusion

This longitudinal EWAS in children with obesity shows that specific blood DNA methylation signatures mirror IR status and track its evolution across the pubertal transition, with opposing methylation trajectories distinguishing improving from persistent IR.

Study context

Population
Children with obesity followed from pre-pubertal to pubertal stage (PUBMEP study); Insulin resistance (IR) defined by sex- and pubertal stage specific HOMA-IR cut-offslongitudinal core
Participants
90 children
Outcome
Association between IR status/trajectories and blood DNA methylation
Follow-up
Pre-pubertal to pubertal stages
Methodological detailscross-sectional analyses, mQTL analyses, Cross-sectional sets: 99 pre-pubertal and 129 pubertal participants
  • Cross-sectional analyses
  • mQTL analyses
  • Cross-sectional sets: 99 pre-pubertal and 129 pubertal participants

Main finding

As reported in the abstract

CpG sites associated with obesity-associated IR across pubertal transition
CpG sites significant after global FDR correction (FDR < 0.05)
120

Observational data: associations, not effects.

Further findings

Candidate loci and cardiometabolic traits · pubertal stage

Methylation at CpG sites in SLC2A9, PEPD, TSC2, EGLN3, EHD2 and VASN consistently associated with pubertal HOMA-IR z-score and, for several loci, adiposity and blood pressure

mQTL look-up in GoDMC

Cis SNP–CpG associations
25
CpG sites (of 120) with cis mQTL, incl. SLC2A9 and TSC2
20

Original publication

Novel epigenetic marks of insulin resistance trajectories in a longitudinal study of childhood obesity. Cardiovasc Diabetol. Published 24 February 2026. doi:10.1186/s12933-026-03101-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.